Crossmark

In vivo macrophage engineering for renal cancer therapy

Crossref DOI link: https://doi.org/10.1038/s43018-025-00912-7

Published Online: 2025-04-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Basílio-Queirós, Débora

Lachmann, Nico https://orcid.org/0000-0002-4245-1497
License Information

Text and Data Mining valid from 2025-04-29

Version of Record valid from 2025-04-29
More Information

Article History

First Online: 29 April 2025

Competing interests

: N.L. is author of a patent application PCT/EP2018/061574 in the scope of macrophage manufacturing. D.B.-Q. declares no competing interests.